AI assistant
Sending…
RESMED INC — Director's Dealing 2022
Jan 11, 2022
30071_dirs_2022-01-11_e0b2518e-fdd5-429a-b59d-316f839dc459.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-01-10
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-10 | ResMed Common Stock | M | 2500 | $57.76 | Acquired | 108854 | Direct |
| 2022-01-10 | ResMed Common Stock | S | 2500 | $235.00 | Disposed | 106354 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-10 | ResMed Common Stock Options | $57.76 | M | 2500 | Disposed | 2023-11-16 | ResMed Common Stock (2500) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29